ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2459
0,00%
Bitcoin
67.553,27
0,11%
Brent Oil
81,295
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Genenta Science SPA (GNTA)

  7. Genenta Science SPA (GNTA) Notícias

GNTA

Genenta Science (GNTA)

Genenta Science SPA
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:GNTA
DataHoraFonteTítuloCódigoCompanhia
06/05/202407:25GlobeNewswire Inc.Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd WiderNASDAQ:GNTAGenenta Science SPA
12/02/202418:05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GNTAGenenta Science SPA
08/02/202407:00GlobeNewswire Inc.Genenta Demonstrated Reprogramming of the Tumor Microenvironment in GBM Patients, Paving the Way for Innovative Treatments of Solid TumorsNASDAQ:GNTAGenenta Science SPA
20/10/202317:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GNTAGenenta Science SPA
06/09/202308:00GlobeNewswire Inc.Genenta to Present at Upcoming Scientific and Investor ConferencesNASDAQ:GNTAGenenta Science SPA
28/07/202304:00GlobeNewswire Inc.Genenta Announces Ongoing Clinical Trial Progress and Proposed Expansion in Solid Tumor TreatmentsNASDAQ:GNTAGenenta Science SPA
29/06/202308:00GlobeNewswire Inc.The European Commission Grants Orphan Drug Designation to Temferon™ for Treatment of GliomaNASDAQ:GNTAGenenta Science SPA
25/05/202307:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GNTAGenenta Science SPA
16/05/202308:00GlobeNewswire Inc.Genenta to Provide Update on Lead Product Temferon™NASDAQ:GNTAGenenta Science SPA
12/05/202318:13Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:GNTAGenenta Science SPA
01/05/202317:06Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:GNTAGenenta Science SPA
26/04/202308:00GlobeNewswire Inc.Genenta Announces Fiscal Year 2022 Financial Results and Annual Report on Form 20-F FilingNASDAQ:GNTAGenenta Science SPA
21/04/202318:23Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:GNTAGenenta Science SPA
10/02/202308:10Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GNTAGenenta Science SPA
26/10/202219:45TipRanksMaxim Group Remains a Buy on Genenta Science SpA Sponsored ADR (GNTA)NASDAQ:GNTAGenenta Science SPA
25/07/202207:00GlobeNewswire Inc.AmCham Italy and Genenta Science Announce the Bowling Green Bull InitiativeNASDAQ:GNTAGenenta Science SPA
15/06/200911:47PR Newswire (US)The following is an investment opinion release issued by EmergingStockReport.comNASDAQ:GNTA
15/05/200911:48PR Newswire (US)Stock Alerts on Market Movers: NGRN, RMBS, NVLS, LVS, GNTA, AN; Issued by Beacon EquityNASDAQ:GNTA
06/03/200921:36Dow Jones NewsGenta: FDA Favors Clinical Trial For Leukemia Drug GenasenseNASDAQ:GNTAGenta Inc.
06/03/200920:34Business WireFDA Appeal Decision Indicates that Genasense® Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory ...NASDAQ:GNTAGenenta Science SPA
13/02/200919:10Business WireGenta Incorporated Announces Fourth Quarter and Year End 2008 Financial Results and Corporate HighlightsNASDAQ:GNTAGenenta Science SPA
07/01/200916:02PR Newswire (US)Beacon Equity Issues Technical Trade Alerts on Newsworthy Market Movers: WLT, SSCC, FNSR, CHTR, STSI, GNTANASDAQ:GNTA
15/09/200809:05PR Newswire (US)Independent Monitoring Board Recommends Completion of Accrual to Genasense(R) Phase 3 AGENDA Trial in Advanced MelanomaNASDAQ:GNTA
07/08/200809:00PR Newswire (US)Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate HighlightsNASDAQ:GNTA
31/07/200809:00PR Newswire (US)Genta Announces Second Quarter 2008 Financial Results and Conference CallNASDAQ:GNTA
15/07/200810:20PR Newswire (US)BeaconEquity.com Issues TraderNotes on Active Stocks: CELI, UVSE, GSPG, GNTA, AAPL, IMMU, EXAS, EEENASDAQ:GNTA
14/07/200809:05PR Newswire (US)FDA Accepts Genta's NDA Amendment as Complete Response for Genasense(R) Treatment of Chronic Lymphocytic LeukemiaNASDAQ:GNTA
08/07/200812:00PR Newswire (US)BeaconEquity.com Issues TraderNotes on Active Stocks: REGRF, PASO, QMNM, UAUA, CBAK, SMOD, GNTA, YHOONASDAQ:GNTA
03/07/200811:20PR Newswire (US)BeaconEquity.com Issues TraderNotes on Active Stocks: ERII, EXTR, IDXX, NSTR, CMLS, JAKK, MPWR, GNTANASDAQ:GNTA
24/06/200809:00PR Newswire (US)Genta Updates Progress of its Phase 3 Trial of Genasense(R) in Patients with Advanced MelanomaNASDAQ:GNTA
 Apresentando as notícias mais relevantes sobre:NASDAQ:GNTA

Seu Histórico Recente

BIT
UC2HD4
UniCredit Bank
COIN
ORLYEUR
COIN
OHMSETH
USOTC
SSNHZ
Samsung Electronics (PK)
EU
N643S
N643S
NASDAQ
INDB
Independent Bank
LSE
75RW
Hsbc Bk. 26
USOTC
TACYY
Total Access Comm (PK)
LSE
ZZ91
Mfpr China 50 A
LSE
RWE
Renewable Energy Generation
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados